Bottom line
FXH vs RSPH: the short answer
FXH (First Trust Health Care AlphaDEX Fund) and RSPH (Invesco S&P 500 Equal Weight Health Care ETF) are quite different portfolios: only about 16% of their top holdings (by weight) are shared.
RSPH is cheaper at 0.4% vs 0.61% — a difference of $21 a year per $10,000 invested.
Over five years, RSPH returned +4.7% a year vs +4.5% for FXH (reporting dates differ).
Updated Nov 19, 2026
FXH vs RSPH side by side
| FXH | RSPH | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | First Trust | Invesco |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.61% | 0.4% |
| Annual cost per $10k | $61 | $40 |
| 10-yr cost on $10k (prospectus) | — | $505 |
| Max front load | None | None |
| 12b-1 fee | 0% | — |
| 1-yr return | +1.1% | +9.3% |
| 5-yr return (annualized) | +4.5% | +4.7% |
| 10-yr return (annualized) | +5.7% | +8.2% |
| Best quarter | +22.2% | +17.5% |
| Worst quarter | −18.8% | −14.3% |
| Net assets (fund) | $1.0B | $766.9M |
| Number of holdings | 75 | 63 |
| Portfolio turnover | 85% | 24% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | FXH | RSPH | Difference |
|---|---|---|---|
| 2024 | +1.1% | −0.8% | +1.9% |
| 2023 | −4.5% | +3.9% | −8.4% |
| 2022 | −12.2% | −9.2% | −3.0% |
| 2021 | +15.2% | +23.0% | −7.9% |
| 2020 | +27.9% | +18.9% | +8.9% |
| 2019 | +22.3% | +25.3% | −3.0% |
| 2018 | −1.3% | −0.3% | −0.9% |
| 2017 | +21.8% | +23.4% | −1.6% |
| 2016 | −5.2% | −4.5% | −0.7% |
| 2015 | +0.2% | +8.2% | −8.0% |
Source: Fund prospectus bar charts
Holdings overlap
4 of FXH's top 25 holdings also appear in RSPH's top 25.
| Holding | FXH | RSPH |
|---|---|---|
| Regeneron Pharmaceuticals Inc | 2.77% | 1.96% |
| Universal Health Services Inc | 2.57% | 1.80% |
| Davita Inc | 2.44% | 1.87% |
| Incyte Corp | 1.78% | 1.76% |
Source: SEC Form N-PORT
FXH top 10
- Regeneron Pharmaceuticals Inc — 2.77%
- Universal Health Services Inc — 2.57%
- Solventum Corp — 2.51%
- Boston Scientific Corp — 2.48%
- Zimmer Biomet Holdings Inc — 2.47%
- Guardant Health Inc — 2.45%
- Davita Inc — 2.44%
- Pfizer Inc — 2.35%
- Tenet Healthcare Corp — 2.30%
- Cigna Group (the) — 2.29%
RSPH top 10
- Bio-Techne Corp. — 2.13%
- IQVIA Holdings Inc. — 2.00%
- Baxter International Inc. — 1.99%
- Regeneron Pharmaceuticals, Inc. — 1.96%
- Mettler-Toledo International Inc. — 1.94%
- Charles River Laboratories International, Inc. — 1.93%
- Veeva Systems Inc. — 1.93%
- DaVita Inc. — 1.87%
- Moderna, Inc. — 1.85%
- Thermo Fisher Scientific Inc. — 1.84%
FAQ
What is the difference between FXH and RSPH?
Which is cheaper, FXH or RSPH?
Should I own both FXH and RSPH?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.